What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary areas of investigation include Internal medicine, Gastroenterology, Fatty liver, Nonalcoholic fatty liver disease and Liver biopsy.
He combines topics linked to Endocrinology with his work on Internal medicine.
Rohit Loomba has included themes like Prospective cohort study, Surgery, Diabetes mellitus, Insulin resistance and Placebo in his Gastroenterology study.
Rohit Loomba works mostly in the field of Placebo, limiting it down to topics relating to Randomized controlled trial and, in certain cases, Placebo-controlled study, as a part of the same area of interest.
His Fatty liver research integrates issues from Chronic liver disease, Liver disease, Metabolic syndrome and Liver cancer.
His Nonalcoholic fatty liver disease study integrates concerns from other disciplines, such as Biomarker, Steatosis, Transient elastography and Receiver operating characteristic.
His most cited work include:
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (1266 citations)
- The global NAFLD epidemic (929 citations)
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies (684 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Fatty liver and Fibrosis.
The study of Internal medicine is intertwined with the study of Cardiology in a number of ways.
His research investigates the link between Gastroenterology and topics such as Placebo that cross with problems in Randomized controlled trial.
His study in Nonalcoholic fatty liver disease is interdisciplinary in nature, drawing from both Body mass index, Liver disease, Magnetic resonance imaging and Chronic liver disease.
The concepts of his Fatty liver study are interwoven with issues in Biomarker, Endocrinology and Metabolic syndrome.
His biological study spans a wide range of topics, including Nonalcoholic steatohepatitis and Magnetic resonance elastography.
He most often published in these fields:
- Internal medicine (59.59%)
- Gastroenterology (32.57%)
- Nonalcoholic fatty liver disease (25.54%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (59.59%)
- Gastroenterology (32.57%)
- Nonalcoholic fatty liver disease (25.54%)
In recent papers he was focusing on the following fields of study:
Rohit Loomba mainly investigates Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Fibrosis and Fatty liver.
Many of his studies involve connections with topics such as Cardiology and Internal medicine.
Rohit Loomba has researched Gastroenterology in several fields, including Diabetes mellitus, Placebo and Cohort.
His research integrates issues of Magnetic resonance imaging, Type 2 diabetes, Metabolic syndrome and Clinical trial in his study of Nonalcoholic fatty liver disease.
The Fatty liver study combines topics in areas such as Magnetic resonance elastography and Elastography.
His Cirrhosis study incorporates themes from Microbiome and Hepatocellular carcinoma.
Between 2019 and 2021, his most popular works were:
- Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. (580 citations)
- Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement. (163 citations)
- In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. (150 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Rohit Loomba mainly focuses on Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Fibrosis and Cirrhosis.
His study in Hepatocellular carcinoma, Steatohepatitis, Liver biopsy, Confidence interval and Odds ratio is carried out as part of his Internal medicine studies.
His Gastroenterology research incorporates themes from Proton density fat fraction, Placebo and Fatty liver.
His research in Nonalcoholic fatty liver disease intersects with topics in Biomarker, Prospective cohort study, Metabolic syndrome and Type 2 diabetes.
As a part of the same scientific study, Rohit Loomba usually deals with the Fibrosis, concentrating on Agonist and frequently concerns with Urology, Regression, Resolution and Adiponectin.
The study incorporates disciplines such as Microbiome, Genetics and Decompensation in addition to Cirrhosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
